US announces drug treatment for sickle cell anaemiaBMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6976.352 (Published 11 February 1995) Cite this as: BMJ 1995;310:352
The first drug treatment for severe sickle cell anaemia has been announced by the National Heart, Lung, and Blood Institute in the US. The drug, hydroxyurea, proved so effective in reducing painful episodes (crises) in adult patients with sickle cell anaemia that a study in 21 centres across the US and Canada of 299 patients with the disease was stopped four months earlier than planned.
The institute issued a two page clinical alert to American doctors last month, saying: “Physicians …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial